Breast Cancer - Best of Breast Cancer 2022
2022 Best of Breast Cancer winners
The JBCS editorial committee has selected the following as the most influential articles from Breast Cancer:
- Japanese subgroup analysis of the phase 3 MONARCH 3 study of abemaciclib as initial therapy for patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer (this opens in a new tab)
- Interstitial lung disorders following postoperative radiotherapy with concurrent or sequential hormonal therapy for breast cancer: a nationwide database study in Japan (this opens in a new tab)